Annals of Neurology · 2011 · 119 citations · 46 references
Life SciencesNeurosciencePathobiologyHemodynamic ManagementInflammationNeuroimmunologyAcute Ischemic StrokeCerebrovascular DiseaseHypoxic-ischemic Brain InjuryNeuroprotectionNeurovascular DysfunctionStrokeBlood-brain Barrier PermeabilityCerebral Ischemic ToleranceCerebrovascular InflammationHypoxiaHypoxic PreconditioningIntermittent HypoxiaIschemic HypoxiaRodent Cerebral Ischemia
OBJECTIVE: Brief systemic hypoxia protects the rodent brain from subsequent ischemic injury, although the protection wanes within days. We hypothesized that the duration of ischemic tolerance could be extended from days to months by repeated intermittent hypoxia of varying magnitude and duration. METHODS: Infarction volumes following a 60-minute transient middle cerebral artery occlusion were determined in adult male mice 2 days through 8 weeks after completion of a 2-week repetitive hypoxic preconditioning (RHP) protocol. Separate cohorts were studied for the protective effects of RHP on postischemic and cytokine-induced cerebrovascular inflammation, and for potential deleterious effects of the RHP stimulus itself. RESULTS: RHP protection against transient focal stroke persisted for 8 weeks. Leukocyte adherence to cortical venules was attenuated in response to stroke, as well as following tumor necrosis factor-α administration, indicating that reductions in postischemic inflammation were not secondary to smaller infarct volumes. RHP reduced poststroke leukocyte diapedesis concomitant with a long-lasting downregulation of endothelial adhesion molecule mRNAs, and also reduced postischemic blood--brain barrier permeability to endogenous immunoglobulin G. RHP was without effect on hippocampal CA1 pyramidal cell viability, only transiently elevated hematocrit, and did not affect the magnitude of cerebral blood flow during and after ischemia. INTERPRETATION: Taken together, our findings reveal a novel form of epigenetic neurovascular plasticity characterized by a prominent anti-inflammatory phenotype that provides protection against stroke many weeks longer than previously established windows of preconditioning-induced tolerance. Translating these endogenous protective mechanisms into therapeutics could afford sustained periods of cerebroprotection in subpopulations of individuals at identified risk for stroke.
46
Heart Disease and Stroke Statistics—2010 Update
Donald M. Lloyd‐Jones, Robert J. Adams, Todd M. Brown et al. · Circulation · 2009 · 5.6K citations
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
H. Klar Yaggi, John Concato, Walter N. Kernan et al. · New England Journal of Medicine · 2005 · 3K citations · Full text
A Semiautomated Method for Measuring Brain Infarct Volume
Raymond A. Swanson, Matthew T. Morton, George Tsao-Wu et al. · Journal of Cerebral Blood Flow & Metabolism · 1990 · 1.7K citations
Medicine, Neurology, Neuroscience +16